Amendment to 4.75% Senior Convertible NotesAmendment to 4.75% Senior Convertible Notes • April 29th, 2009 • Novavax Inc • Biological products, (no disgnostic substances)
This amendment agreement (this “Amendment”) dated as of April 28, 2009 to the 4.75% senior convertible notes issued pursuant to the Purchase Agreement (as defined below) (the “Notes”) is made by and between Novavax, Inc., a Delaware corporation (the “Company”) and Smithfield Fiduciary LLC (the “Required Holder”).
